Cardiac Electrophysiology Research and Training Center, Department of Physiology, Faculty of Medicine.
Heart Rhythm. 2013 Nov;10(11):1700-7. doi: 10.1016/j.hrthm.2013.08.009. Epub 2013 Aug 8.
Right cervical vagus nerve stimulation (VNS) provides cardioprotective effects against acute ischemia-reperfusion injury in small animals. However, inconsistent findings have been reported.
To determine whether low-amplitude, left cervical VNS applied either intermittently or continuously imparts cardioprotection against acute ischemia-reperfusion injury.
Thirty-two isoflurane-anesthetized swine (25-30 kg) were randomized into 4 groups: control (sham operated, no VNS), continuous-VNS (C-VNS; 3.5 mA, 20 Hz), intermittent-VNS (I-VNS; continuously recurring cycles of 21-second ON, 30-second OFF), and I-VNS + atropine (1 mg/kg). Left cervical VNS was applied immediately after left anterior descending artery occlusion (60 minutes) and continued until the end of reperfusion (120 minutes). The ischemic and nonischemic myocardium was harvested for cardiac mitochondrial function assessment.
VNS significantly reduced infarct size, improved ventricular function, decreased ventricular fibrillation episodes, and attenuated cardiac mitochondrial reactive oxygen species production, depolarization, and swelling, compared with the control group. However, I-VNS produced the most profound cardioprotective effects, particularly infarct size reduction and decreased ventricular fibrillation episodes, compared to both I-VNS + atropine and C-VNS. These beneficial effects of VNS were abolished by atropine.
During ischemia-reperfusion injury, both C-VNS and I-VNS provide significant cardioprotective effects compared with I-VNS + atropine. These beneficial effects were abolished by muscarinic blockade, suggesting the importance of muscarinic receptor modulation during VNS. The protective effects of VNS could be due to its protection of mitochondrial function during ischemia-reperfusion.
右侧颈迷走神经刺激(VNS)可提供针对小动物急性缺血再灌注损伤的心脏保护作用。然而,目前的研究结果并不一致。
确定间歇或连续施加低幅度左侧颈 VNS 是否对急性缺血再灌注损伤具有心脏保护作用。
32 头异氟烷麻醉猪(25-30 kg)随机分为 4 组:对照组(假手术,无 VNS)、连续 VNS 组(C-VNS;3.5 mA,20 Hz)、间歇 VNS 组(I-VNS;连续循环 21 秒 ON,30 秒 OFF)和 I-VNS + 阿托品组(1 mg/kg)。在左前降支闭塞(60 分钟)后立即施加左侧颈 VNS,并持续至再灌注结束(120 分钟)。缺血和非缺血心肌用于评估心脏线粒体功能。
与对照组相比,VNS 显著减少梗死面积,改善心室功能,减少室颤发作,并减轻心脏线粒体活性氧产生、去极化和肿胀。然而,与 I-VNS + 阿托品和 C-VNS 相比,I-VNS 产生了最显著的心脏保护作用,特别是梗死面积减少和室颤发作减少。VNS 的这些有益作用被阿托品消除。
在缺血再灌注损伤期间,与 I-VNS + 阿托品相比,C-VNS 和 I-VNS 均可提供显著的心脏保护作用。这些有益作用被毒蕈碱受体阻断所消除,提示在 VNS 期间调节毒蕈碱受体的重要性。VNS 的保护作用可能是由于其在缺血再灌注期间对线粒体功能的保护。